SANOFI3,109.80

Sanofi India Limited

· Pharma & Health
₹ CrorePeersSENORESINNOVACAPPGHLMOREPENLABIOLCPSANOFICONRFDCORCHPHARMAMcap ₹7,153 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/12/2022
FY24
31/12/2023
FY25
31/12/2024
Non-current Assets
+ Property, Plant & Equipment305.2310.0255.8
+ Capital Work-in-Progress18.813.318.1
+ Other Intangibles4.956.7
+ Intangibles under Development4.82.6
+ Other Non-current Financial Assets11.112.7
Non-current Financial Assets11.112.7
+ Deferred Tax Assets0.1
+ Other Non-current Assets124.94.1
Total Non-current Assets461.4466.8347.5
Current Assets
+ Inventories408.0663.8499.8
+ Trade Receivables129.1131.7230.0
+ Cash & Cash Equivalents1,004.9394.5283.8
+ Other Bank Balances12.012.011.0
+ Short-term Loans1.91.0
+ Other Current Financial Assets7.845.2
Current Financial Assets1,146.0547.9571.0
+ Other Current Assets46.336.356.0
Total Current Assets1,610.31,248.01,264.3
Total Assets2,071.71,714.81,611.8
Equity
+ Equity Share Capital23.023.023.0
+ Other Equity / Reserves992.2837.6
Equity — Owners of Parent1,015.2860.6
Total Equity1,275.81,015.2860.6
Liabilities
+ Other Non-current Financial Liab13.914.0
Non-current Financial Liabilities13.914.0
+ Provisions — Non-current30.70.0
+ Deferred Tax Liabilities3.7
+ Other Non-current Liabilities18.0
Non-current Liabilities55.348.332.0
+ Trade Payables291.5406.3
+ Other Current Financial Liab21.839.7
Current Financial Liabilities313.3446.0
+ Provisions — Current226.9118.5
+ Current Tax Liabilities90.0101.595.9
+ Other Current Liabilities17.69.658.8
Current Liabilities740.6651.3719.2
Total Liabilities699.6751.2
Total Equity & Liabilities2,071.71,714.81,611.8
Assets — additional as-filed lines
+ Current Tax Assets137.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.